HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J supports BASF ingredient

This article was originally published in The Rose Sheet

Executive Summary

FDA should expedite review of BASF's Time & Extent Application for UVB absorber octyl triazone, marketed in Europe as Uvinul T-150, Johnson & Johnson says in an Oct. 7 letter to the agency. While J&J "has no experience with this ingredient, we are aware of the limited choices available for sunscreen actives," company states. BASF first petitioned FDA to designate octyl triazone a Category I sunscreen ingredient in November 1996, based on foreign marketing experience (1"The Rose Sheet" Dec. 2, 1996, p. 8). The ingredient has been marketed in Europe since 1989 and in Japan since 1996. FDA barred interim marketing of OTC drugs in the U.S. in its final rule on "material time, material extent" criteria, and noted pending citizen petitions from sunscreen ingredient suppliers could be converted to TEAs for agency consideration of monograph eligibility (2"The Rose Sheet" Jan. 29, 2002, p. 8)...

You may also be interested in...

FDA “Material Time, Material Extent” May Be Cloudy For Sunscreens

Interim marketing for OTC drugs or "conditions" in the U.S. subject to a final or new monograph is barred under FDA's final rule on "material time, material extent" criteria

Octyl triazone inclusion in sunscreen TFM based on foreign use data sought by BASF.

OCTYL TRIAZONE INCLUSION IN SUNSCREEN MONOGRAPH SOUGHT BY BASF AG as a Category I (generally recognized as safe and effective) sunscreen ingredient on the basis of its foreign marketing experience. In a Nov. 15 petition filed by the Washington, D.C. office of Morgan, Lewis & Bockius, Germany-based BASF asks FDA to reopen the administrative record of the OTC Sunscreen Drug Products review to include octyl triazone, which the company sells overseas under the trade name Uvinul T 150. The ingredient was approved in the European Union in 1989 and in Japan in March.

EU Off-Patent Industry Sees ‘Limited Immediate Risk’ From COVID-19

 The coronavirus COVID-19 outbreak poses a “limited immediate risk” to European production and supplies of off-patent drugs, according to industry association Medicines for Europe. However, if the situation continues for an extended period an “important impact” cannot be ruled out.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts